With the emergence of the Omicron variant, ASM reiterates our commitment to advocate for increased genomic sequencing and surveillance programs, vaccine equity and global leadership.

Is Mixing-and-Matching safe and effective? Which COVID-19 vaccine is best? And do differences in dosage and wait times between doses impact vaccine performance?

What are the risks of a circulating, pandemic respiratory virus clashing with the imminent flu season? To predict how SARS-CoV-2 and influenza virus might interact, we break down the attributes of COVID-19 and the flu.